End Price Gouging for Medications Act

The End Price Gouging for Medications Act establishes annual reference prices for prescription drugs based on the lowest retail prices in 12 international reference countries (like Canada and the UK) or specific criteria if international data is unavailable. It requires drug manufacturers to sell medications at or below these reference prices for all patients covered by federal health programs - including Medicare, Medicaid, TRICARE, and VA care - as well as for all other patients, including those with private insurance. Manufacturers violating this rule face civil penalties of five times the revenue difference, with collected funds directed to the National Institutes of Health for drug research. This bill directly affects drug manufacturers and millions of Americans enrolled in the specified federal health programs.